摘要
多巴酚丁胺试验是近年来开展的一项诊断冠心病的新技术。对12例患者进行了^(201)TL-多巴酚丁胺试验心肌灌注显像,给予的最大负荷剂量为20μg/(kg·min),取得了满意的效果。它是一种很有应用前途的诊断方法,但也有操作较复杂和试验时间较长等缺点。
The value of dobutamine thallium-201 SPECT(Dobu-test)for detecting coronary artery disease (CAD)was assessed in 12 patients. The maximum dose of dobutamine was 20μg·kg-1·min-1. No serious side effects were observed in this study. The results showed that Dobu-test is a feasible ,safe and noninvasive method for diagnosing CAD,but the procedure is complicated and takes a long time.
出处
《天津医药》
CAS
1997年第1期28-29,共2页
Tianjin Medical Journal
